Send us Feedback

Keryx Biopharmaceuticals (KERX)
Analysis
Data
Financials
Key Metrics for KERX as compared to All values TTM unless otherwise noted (*)
INDUSTRY METRICS  (See all)
Revenue ►25.5MAVG
R&D Expense ►38.0MHIGH
Gross Margin ►97.9% 
R&D/Sales Ratio ►2962.4%HIGH
Number of Drugs in Phase II ►2.00LOW
 
INCOME STATEMENT  (See all)
Revenue ►25.5MAVG
EBITDA ►9.88MHIGH
Net Income ►11.3MVERY HIGH
Revenue Growth ►1271.4%VERY HIGH
Operating Margin ►50.2%HIGH
Net Margin ►44.4%HIGH
 
BALANCE SHEET (most recent quarter)  (See all)
Debt / Equity ►0.300AVG
Current Ratio ►5.40HIGH
Quick Ratio ►5.40HIGH
Interest Coverage Ratio ►-6.31AVG
Book Value Per Share ►0.624 
Cash Per Share ►0.602 
Loading...
STOCK SUMMARY
Open
Day Range-
52 Week Range-
Volume
Avg Volume (3 mo)
Shares Outstanding
Market Cap
ANALYST RECOMMENDATIONS
 
OWNERSHIP
Net Insider Buying 3mo0% 
Net Insider Buying 6mo0.2% 
Net Insider Buying 1yr4.7% 
Held by insiders2.3% 
Held by institutions1.2% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki